Literature DB >> 20650621

Immune mechanisms of HIV control.

Lisa A Chakrabarti1, Viviana Simon.   

Abstract

HIV-1 can be contained by the immune system, as demonstrated by the existence of rare individuals who spontaneously control HIV-1 replication in the absence of antiretroviral therapy. Emerging evidence points to the importance of a very active cellular immune response in mediating HIV-1 control. The rapid induction of interferon-dependent HIV restriction factors, the presence of protective MHC class I alleles, and the development of a high avidity T-cell response may all cooperate in limiting HIV replication at an early stage. This review will focus on recent advances in understanding the immune mechanisms of HIV control, and on the lessons that may be drawn for the development of candidate HIV vaccines. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650621      PMCID: PMC3039284          DOI: 10.1016/j.coi.2010.06.006

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  67 in total

1.  Rapid culling of the CD4+ T cell repertoire in the transition from effector to memory.

Authors:  Matthew A Williams; Eugene V Ravkov; Michael J Bevan
Journal:  Immunity       Date:  2008-03-20       Impact factor: 31.745

2.  Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.

Authors:  Amélie Guihot; Roland Tubiana; Guillaume Breton; Anne-Geneviève Marcelin; Assia Samri; Lambert Assoumou; Emilia Goncalves; François Bricaire; Dominique Costagliola; Vincent Calvez; Christine Rouzioux; Brigitte Autran; Christine Katlama; Guislaine Carcelain
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

3.  Interferon-alpha produces significant decreases in HIV load.

Authors:  Jorge A Tavel; Chiung-Yu Huang; Jean Shen; Julia A Metcalf; Robin Dewar; Akram Shah; M B Vasudevachari; Dean A Follmann; Betsey Herpin; Richard T Davey; Michael A Polis; Joseph Kovacs; Henry Masur; H Clifford Lane
Journal:  J Interferon Cytokine Res       Date:  2010-07       Impact factor: 2.607

4.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

5.  Innate immune responses in primary HIV-1 infection.

Authors:  Persephone Borrow; Nina Bhardwaj
Journal:  Curr Opin HIV AIDS       Date:  2008-01       Impact factor: 4.283

6.  Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?

Authors:  Cécile Goujard; Marie-Laure Chaix; Olivier Lambotte; Christiane Deveau; Martine Sinet; Julien Guergnon; Valérie Courgnaud; Christine Rouzioux; Jean-François Delfraissy; Alain Venet; Laurence Meyer
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

7.  Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy.

Authors:  Stephen A Migueles; Kristin A Weeks; Eric Nou; Amy M Berkley; Julia E Rood; Christine M Osborne; Claire W Hallahan; Nancy A Cogliano-Shutta; Julia A Metcalf; Mary McLaughlin; Richard Kwan; JoAnn M Mican; Richard T Davey; Mark Connors
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

8.  Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals.

Authors:  Ping An; Priya Duggal; Li Hua Wang; Stephen J O'Brien; Sharyne Donfield; James J Goedert; John Phair; Susan Buchbinder; Gregory D Kirk; Cheryl A Winkler
Journal:  PLoS Genet       Date:  2007-01-26       Impact factor: 5.917

9.  Common genetic variation and the control of HIV-1 in humans.

Authors:  Jacques Fellay; Dongliang Ge; Kevin V Shianna; Sara Colombo; Bruno Ledergerber; Elizabeth T Cirulli; Thomas J Urban; Kunlin Zhang; Curtis E Gumbs; Jason P Smith; Antonella Castagna; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Huldrych F Günthard; Simon Mallal; Cristina Mussini; Judith Dalmau; Javier Martinez-Picado; José M Miro; Niels Obel; Steven M Wolinsky; Jeremy J Martinson; Roger Detels; Joseph B Margolick; Lisa P Jacobson; Patrick Descombes; Stylianos E Antonarakis; Jacques S Beckmann; Stephen J O'Brien; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Mary Carrington; Sheng Feng; Amalio Telenti; David B Goldstein
Journal:  PLoS Genet       Date:  2009-12-24       Impact factor: 5.917

10.  Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.

Authors:  Jorge R Almeida; David A Price; Laura Papagno; Zaïna Aït Arkoub; Delphine Sauce; Ethan Bornstein; Tedi E Asher; Assia Samri; Aurélie Schnuriger; Ioannis Theodorou; Dominique Costagliola; Christine Rouzioux; Henri Agut; Anne-Geneviève Marcelin; Daniel Douek; Brigitte Autran; Victor Appay
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  17 in total

1.  HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence.

Authors:  Tatiana Koudriavtseva; Domenico Plantone; Chiara Mandoj; Diana Giannarelli; Alessandra Latini; Manuela Colafigli; Elisabetta Trento; Paola Cordiali-Fei; Fulvia Pimpinelli
Journal:  J Neurovirol       Date:  2016-07-18       Impact factor: 2.643

Review 2.  Regional and mucosal memory T cells.

Authors:  Brian S Sheridan; Leo Lefrançois
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 3.  Human memory T cells: generation, compartmentalization and homeostasis.

Authors:  Donna L Farber; Naomi A Yudanin; Nicholas P Restifo
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

4.  Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses.

Authors:  Theodros S Tsegaye; Katherine Butler; Wei Luo; Jessica Radzio; Priya Srinivasan; Sunita Sharma; Rachael D Aubert; Debra L Hanson; Charles Dobard; Jose Gerardo Garcia-Lerma; Walid Heneine; Janet M McNicholl; Ellen N Kersh
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-01       Impact factor: 3.731

5.  Multiple sclerosis and HIV-1 infection: case report of a HIV controller.

Authors:  Jerome H Chin
Journal:  J Neurovirol       Date:  2015-03-24       Impact factor: 2.643

6.  A novel aminoacid determinant of HIV-1 restriction in the TRIM5α variable 1 region isolated in a random mutagenic screen.

Authors:  Quang Toan Pham; Maxime Veillette; Alberto Brandariz-Nuñez; Paulina Pawlica; Caroline Thibert-Lefebvre; Nadia Chandonnet; Felipe Diaz-Griffero; Lionel Berthoux
Journal:  Virus Res       Date:  2013-01-25       Impact factor: 3.303

7.  HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term.

Authors:  Benoît Vingert; Daniela Benati; Olivier Lambotte; Pierre de Truchis; Laurence Slama; Patricia Jeannin; Moran Galperin; Santiago Perez-Patrigeon; Faroudy Boufassa; William W Kwok; Fabrice Lemaître; Jean-François Delfraissy; Jacques Thèze; Lisa A Chakrabarti
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

8.  DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers.

Authors:  Madhura Mukhopadhyay; Moran Galperin; Mandar Patgaonkar; Sandhya Vasan; David D Ho; Alexandre Nouël; Mathieu Claireaux; Daniela Benati; Olivier Lambotte; Yaoxing Huang; Lisa A Chakrabarti
Journal:  J Immunol       Date:  2017-10-09       Impact factor: 5.422

9.  Public T cell receptors confer high-avidity CD4 responses to HIV controllers.

Authors:  Daniela Benati; Moran Galperin; Olivier Lambotte; Stéphanie Gras; Annick Lim; Madhura Mukhopadhyay; Alexandre Nouël; Kristy-Anne Campbell; Brigitte Lemercier; Mathieu Claireaux; Samia Hendou; Pierre Lechat; Pierre de Truchis; Faroudy Boufassa; Jamie Rossjohn; Jean-François Delfraissy; Fernando Arenzana-Seisdedos; Lisa A Chakrabarti
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

Review 10.  Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?

Authors:  Guido Vanham; Ellen Van Gulck
Journal:  Retrovirology       Date:  2012-09-07       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.